BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26219949)

  • 1. Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure.
    Bradshaw CS; Brotman RM
    BMC Infect Dis; 2015 Jul; 15():292. PubMed ID: 26219949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment.
    Vodstrcil LA; Muzny CA; Plummer EL; Sobel JD; Bradshaw CS
    BMC Med; 2021 Sep; 19(1):194. PubMed ID: 34470644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in the prevention of recurrences of bacterial vaginosis.
    Parma M; Stella Vanni V; Bertini M; Candiani M
    Altern Ther Health Med; 2014; 20 Suppl 1():52-7. PubMed ID: 24473986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal Microbiota.
    Mendling W
    Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
    Russo R; Karadja E; De Seta F
    Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the vaginal microflora in health and disease.
    Datcu R
    Dan Med J; 2014 Apr; 61(4):B4830. PubMed ID: 24814599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-antibiotic treatment of bacterial vaginosis-a systematic review.
    Tidbury FD; Langhart A; Weidlinger S; Stute P
    Arch Gynecol Obstet; 2021 Jan; 303(1):37-45. PubMed ID: 33025086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
    Reid G; Burton J; Hammond JA; Bruce AW
    J Med Food; 2004; 7(2):223-8. PubMed ID: 15298771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it's associated resistance patterns.
    Javed A; Parvaiz F; Manzoor S
    Microb Pathog; 2019 Feb; 127():21-30. PubMed ID: 30502515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection.
    Chandrashekhar P; Minooei F; Arreguin W; Masigol M; Steinbach-Rankins JM
    AAPS J; 2021 May; 23(3):66. PubMed ID: 33973067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa.
    Woodman Z
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():16. PubMed ID: 26968525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence.
    Bilardi J; Walker S; Mooney-Somers J; Temple-Smith M; McNair R; Bellhouse C; Fairley C; Chen M; Bradshaw C
    PLoS One; 2016; 11(3):e0150272. PubMed ID: 26930414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The right bug in the right place: opportunities for bacterial vaginosis treatment.
    Wu S; Hugerth LW; Schuppe-Koistinen I; Du J
    NPJ Biofilms Microbiomes; 2022 May; 8(1):34. PubMed ID: 35501321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of bacterial vaginosis and polymicrobial biofilm formation.
    Jung HS; Ehlers MM; Lombaard H; Redelinghuys MJ; Kock MM
    Crit Rev Microbiol; 2017 Nov; 43(6):651-667. PubMed ID: 28358585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fighting polymicrobial biofilms in bacterial vaginosis.
    Sousa LGV; Pereira SA; Cerca N
    Microb Biotechnol; 2023 Jul; 16(7):1423-1437. PubMed ID: 37042412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.